BHCM
CL icon

Brevan Howard Capital Management’s Colgate-Palmolive CL Stock Holding History

Brevan Howard Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Buy
45,490
+33,581
+282% +$2.94M 0.03% 411
2026
Q1 		$1.02M Buy
11,909
+9,207
+341% +$821K 0.01% 891
2025
Q4 		$214K Buy
+2,702
New +$212K ﹤0.01% 1547
2025
Q3 		– Sell
-15,495
Closed -$1.41M – 1974
2025
Q2 		$1.41M Sell
15,495
-12,326
-44% -$1.13M 0.01% 905
2025
Q1 		$2.61M Buy
+27,821
New +$2.49M 0.03% 246
2024
Q2 		– Sell
-6,484
Closed -$584K – 1103
2024
Q1 		$584K Buy
+6,484
New +$549K 0.01% 411

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Brevan Howard Capital Management's CL Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Colgate-Palmolive (CL) stake by 282% in Q2 2026, buying an estimated $2.94M and bringing the position to 45,490 shares worth $4.17M. The position accounts for 0.03% of the portfolio, ranked #411.

Brevan Howard Capital Management first reported a position in CL in Q1 2024 and has held it in 6 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Brevan Howard Capital Management held 45,490 shares of Colgate-Palmolive worth $4.17M as of Q2 2026.
  • Brevan Howard Capital Management bought 33,581 Colgate-Palmolive shares in Q2 2026, an estimated $2.94M.
  • Colgate-Palmolive made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #411 holding.
  • Brevan Howard Capital Management first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 6 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.